Peter Rossing
Peter Rossing
Steno Diabetes Center
Verified email at
TitleCited byYear
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
MJ Davies, DA D’Alessio, J Fradkin, WN Kernan, C Mathieu, G Mingrone, ...
Diabetologia 61 (12), 2461-2498, 2018
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
CS Fox, K Matsushita, M Woodward, HJG Bilo, J Chalmers, ...
The Lancet 380 (9854), 1662-1673, 2012
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study
P Rossing, P Hougaard, K Borch-Johnsen, HH Parving
Bmj 313 (7060), 779-784, 1996
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease …
BC Astor, K Matsushita, RT Gansevoort, M Van Der Velde, M Woodward, ...
Kidney international 79 (12), 1331-1340, 2011
Prevalence of micro-and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients
MA Gall, P Rossing, P Skøtt, P Damsbo, A Vaag, K Bech, A Dejgaard, ...
Diabetologia 34 (9), 655-661, 1991
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study
P Hovind, L Tarnow, P Rossing, M Graae, I Torp, C Binder, HH Parving
Bmj 328 (7448), 1105, 2004
Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
S Andersen, L Tarnow, P Rossing, BV Hansen, HH Parving
Kidney international 57 (2), 601-606, 2000
Progression of diabetic nephropathy
P Hovind, P Rossing, L Tarnow, UM Smidt, HH Parving
Kidney international 59 (2), 702-709, 2001
Progression of nephropathy in type 2 diabetic patients
K Rossing, PK Christensen, P Hovind, L Tarnow, P Rossing, HH Parving
Kidney international 66 (4), 1596-1605, 2004
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes
P Hovind, L Tarnow, K Rossing, P Rossing, S Eising, N Larsen, C Binder, ...
Diabetes care 26 (4), 1258-1264, 2003
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
BK Mahmoodi, K Matsushita, M Woodward, PJ Blankestijn, M Cirillo, ...
The Lancet 380 (9854), 1649-1661, 2012
Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: the AMETHYST-DN randomized clinical trial
GL Bakris, B Pitt, MR Weir, MW Freeman, MR Mayo, D Garza, Y Stasiv, ...
Jama 314 (2), 151-161, 2015
Urinary proteomics in diabetes and CKD
K Rossing, H Mischak, M Dakna, P Zürbig, J Novak, BA Julian, DM Good, ...
Journal of the American Society of Nephrology 19 (7), 1283-1290, 2008
Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study
P Rossing, P Hougaard, HH Parving
Diabetes care 25 (5), 859-864, 2002
Prevalence of arterial hypertension in diabetic patients before and after the JNC-V
L Tarnow, P Rossing, MA Gall, FS Nielsen, HH Parving
Diabetes care 17 (11), 1247-1251, 1994
Recommendations for biomarker identification and qualification in clinical proteomics
H Mischak, G Allmaier, R Apweiler, T Attwood, M Baumann, A Benigni, ...
Science translational medicine 2 (46), 46ps42-46ps42, 2010
Lack of relationship between an insertion/deletion polymorphism in the angiotensin I–converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients
L Tarnow, F Cambien, P Rossing, FS Nielsen, BV Hansen, L Lecerf, ...
Diabetes 44 (5), 489-494, 1995
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
P Gæde, J Oellgaard, B Carstensen, P Rossing, H Lund-Andersen, ...
Diabetologia 59 (11), 2298-2307, 2016
Beneficial impact of spironolactone in diabetic nephropathy
KJ Schjoedt, K Rossing, TR Juhl, F Boomsma, P Rossing, L Tarnow, ...
Kidney international 68 (6), 2829-2836, 2005
Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational …
HH Parving, P Jacobsen, L Tarnow, P Rossing, L Lecerf, O Poirier, ...
Bmj 313 (7057), 591-594, 1996
The system can't perform the operation now. Try again later.
Articles 1–20